Mds Podcast

In this issue Dr. Sheperjans shares the results of the article published in the March 2020 issue of the Movement Disorders journal on the effect of antibiotic exposure on the risk of developing Parkinson's disease. Read the article

Dr. Schaefer discusses with Dr. Lidstone her recent paper in Movement Disorders Clinical Practice about a novel, multidisciplinary therapeutic intervention for functional movement disorders patients. Read the article

Dr. Dayal discusses with Dr. Matarazzo how adjusting the pulse width of deep brain stimulation could impact Parkinson's disease, highlighting the results of the paper he recently published in the Movement Disorder Journal.

Dr. Schaefer discusses with Dr. Gregory her recent study on neuroimaging changes and fluid biomarkers in Huntington's disease, and how those may be used to better characterize the biological basis for neurodegeneration in this disease.

Dr. Schaefer speaks with Dr. Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions. Read the article

As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Chaudhuri about news in Parkinson’s disease and Lewy body dementia, including new treatments, scales and other advances in early and late-stage PD. Read the article

As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Espay about technology in movement disorders, highlighting recent advances and the goal of the MDS to create a platform that will combine technology-based data and e-diaries.

As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Elble about recent advances in tremor classification, diagnosis and treatment approaches, and about the future plans of the MDS Tremor study group to overcome current challenges for clinicians and researchers.

As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Ganos about the newly created MDS Tic Disorders and Tourette Syndrome Study Group, and the main news breakthroughs in the field, that have been discussed during the MDS Congress.

As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Respondek about atypical parkinsonisms, focusing on the MDS activities to advance in the knowledge and management of these diseases and facilitate clinical trials.

Dr. Schaefer discusses with Dr. Kamel the role of botulinum toxin in the treatment of refractory upper limb tremor, and his center's tailored approach to provide relief for these patients.

As part of the MDS Congress 2019 Special Issue, Dr. Schaefer interviews Dr. Strafella about the emerging research in neuroimaging in movement disorders and plans to establish a centralized database for neuroimaging in atypical parkinsonisms.

As part of the MDS Congress 2019 Special Issue, Dr. Schaefer interviews Dr. Jinnah about notable research in dystonia and activities of the MDS Dystonia Study Group.

As part of the MDS Congress 2019 Special Issue, Dr. Schaefer and Dr. Tabrizi discuss the evolving research in disease-modifying therapies for Huntington's Disease, and what may come next.

As part of the MDS Congress 2019 Special Issue, Dr. Schaefer interviews Dr. Postuma about all of the educational offerings through the MDS, as well as new projects of the MDS Education Committee.

Did you miss the MDS Congress in Nice, or do you just want an overview of highlights from the Congress as well as a look forward at new ventures? Dr. Schaefer introduces the MDS Congress 2019 special issue, which features interviews with experts in various fields of movement disorders at the MDS Congress 2019. In this first issue, Dr. Schaefer interviews Dr. LaFaver about notable research in functional movement disorders, activities of the MDS Functional Movement Disorders Study Group, and more.

In this interview with Dr. Jabbari we highlight the results of his study on the definition and genetic and neuropathological characteristics of early onset progressive supranuclear palsy. The full study is available on the September 2019 issue of the Movement Disorders Journal.

Dr. Farwa Ali discusses with Dr. Schaefer the results of her study on the use of the MDS criteria for PSP with the MAX rules and their clinical implications, as well as the challenges of the phenotype variability of this disease in clinical practice and research.

Dr. Bergsland discusses with Dr. Matarazzo the results of the paper he recently published in the Movement Disorder Journal on longitudinal iron imaging in the substantia nigra in PD and in its different regions.

Benjamin Deck discusses with Dr. Schaefer the article he recently published in the Movement Disorders Clinical Practice on the patient vs. care partner assessment of cognition in Parkinson's disease.